Matches in Wikidata for { <http://www.wikidata.org/entity/Q89534345> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q89534345 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q89534345 description "scientific article published on 04 February 2020" @default.
- Q89534345 description "wetenschappelijk artikel" @default.
- Q89534345 description "наукова стаття, опублікована 4 лютого 2020" @default.
- Q89534345 name "Cost-Neutral Optimization of Pazopanib Exposure by Splitting Intake Moments: A Prospective Pharmacokinetic Study in Cancer Patients" @default.
- Q89534345 name "Cost-Neutral Optimization of Pazopanib Exposure by Splitting Intake Moments: A Prospective Pharmacokinetic Study in Cancer Patients" @default.
- Q89534345 type Item @default.
- Q89534345 label "Cost-Neutral Optimization of Pazopanib Exposure by Splitting Intake Moments: A Prospective Pharmacokinetic Study in Cancer Patients" @default.
- Q89534345 label "Cost-Neutral Optimization of Pazopanib Exposure by Splitting Intake Moments: A Prospective Pharmacokinetic Study in Cancer Patients" @default.
- Q89534345 prefLabel "Cost-Neutral Optimization of Pazopanib Exposure by Splitting Intake Moments: A Prospective Pharmacokinetic Study in Cancer Patients" @default.
- Q89534345 prefLabel "Cost-Neutral Optimization of Pazopanib Exposure by Splitting Intake Moments: A Prospective Pharmacokinetic Study in Cancer Patients" @default.
- Q89534345 P1433 Q89534345-6F707184-F297-49B2-94E3-B22B049C2A5A @default.
- Q89534345 P1476 Q89534345-A06C4E5A-0BE0-48D5-AED1-458EF49C7A11 @default.
- Q89534345 P2093 Q89534345-06B019E1-8305-4305-BE68-F1564D5A9FFB @default.
- Q89534345 P2093 Q89534345-08318E8E-7C4D-4F93-BF23-C8104DF31FDB @default.
- Q89534345 P2093 Q89534345-4B82DC6C-F6D8-4DA9-A147-65A4AD5FDDF9 @default.
- Q89534345 P2093 Q89534345-5FE5AFE6-3F8D-4405-9A3E-6C5392ADCA58 @default.
- Q89534345 P2093 Q89534345-6316F4D5-4D1D-4F47-B056-AE3182F2C63F @default.
- Q89534345 P2093 Q89534345-786633B8-CA84-404F-8718-0435F563C3AC @default.
- Q89534345 P2093 Q89534345-7985D5A8-42E0-45B6-AFFA-B1E36462851D @default.
- Q89534345 P2093 Q89534345-C5D6E1FE-95BC-40DE-84F8-B69939ABE783 @default.
- Q89534345 P2093 Q89534345-C8828BEE-8F21-4758-B9EC-992B3D397132 @default.
- Q89534345 P2093 Q89534345-D974CBEB-EE0A-47DE-A3BF-A8CB6469F49E @default.
- Q89534345 P2093 Q89534345-EAE1792F-F12E-4FB8-92F1-C762B19A523D @default.
- Q89534345 P31 Q89534345-49B20231-91F2-4CF6-ABDF-658C05662EA1 @default.
- Q89534345 P356 Q89534345-10059ED8-F808-47C7-A09B-F85701FE6C7D @default.
- Q89534345 P50 Q89534345-B196DF7C-F9E0-4883-9ED7-C5C6BD85E64F @default.
- Q89534345 P577 Q89534345-A0AEBB3B-FAA2-44DE-9B9E-AA695EDE0FF3 @default.
- Q89534345 P698 Q89534345-9B4C36B1-3690-4EA0-98D5-F6374E409A11 @default.
- Q89534345 P921 Q89534345-8CB733EB-10E9-442E-90FE-C27688AC7223 @default.
- Q89534345 P356 S40262-020-00863-5 @default.
- Q89534345 P698 32020530 @default.
- Q89534345 P1433 Q5133788 @default.
- Q89534345 P1476 "Cost-Neutral Optimization of Pazopanib Exposure by Splitting Intake Moments: A Prospective Pharmacokinetic Study in Cancer Patients" @default.
- Q89534345 P2093 "Alwin D R Huitema" @default.
- Q89534345 P2093 "Bas Thijssen" @default.
- Q89534345 P2093 "Dutch Pharmacology Oncology Group (DPOG)" @default.
- Q89534345 P2093 "Hilde Rosing" @default.
- Q89534345 P2093 "Jos H Beijnen" @default.
- Q89534345 P2093 "Neeltje Steeghs" @default.
- Q89534345 P2093 "Niels de Vries" @default.
- Q89534345 P2093 "Remy B Verheijen" @default.
- Q89534345 P2093 "Ron H J Mathijssen" @default.
- Q89534345 P2093 "Ruben A G van Eerden" @default.
- Q89534345 P2093 "Stijn L W Koolen" @default.
- Q89534345 P31 Q13442814 @default.
- Q89534345 P356 "10.1007/S40262-020-00863-5" @default.
- Q89534345 P50 Q89534343 @default.
- Q89534345 P577 "2020-02-04T00:00:00Z" @default.
- Q89534345 P698 "32020530" @default.
- Q89534345 P921 Q323936 @default.